The Mifepristone Legal Gauntlet
May 15, 2026
63%
SHARE OF U.S. ABORTIONS
performed via medication abortion (2023)
21
STATES WITH BANS/RESTRICTIONS
on mifepristone or medication abortion as of 2025
24+
YEARS OF FDA APPROVAL
mifepristone approved by FDA in September 2000
2
SUPREME COURT RULINGS
2024 standing ruling + 2025 access preservation order
Medication Abortion as Share of All U.S. Abortions
2000–2023 · Source: Guttmacher Institute
63% in 2023
FDA approval
FDA relaxes REMS
Mail-order allowed
Dobbs decision
5th Circuit ruling
Republican administration
Democratic administration
Context & FAQ
Sources: Guttmacher Institute · FDA · Supreme Court of the United States · KFF (Kaiser Family Foundation)
Data sources
Medication Abortion Percentage Data (2000–2023)· Guttmacher InstituteMifepristone REMS Program & Regulatory History· U.S. Food and Drug AdministrationFDA v. Alliance for Hippocratic Medicine — SCOTUS Opinion (2024)· Supreme Court of the United StatesState Abortion Policy Tracker· KFF (Kaiser Family Foundation)Loper Bright Enterprises v. Raimondo — SCOTUS Opinion (2024)· Supreme Court of the United StatesMedication Abortion State Policy Landscape· Guttmacher InstituteMifepristone Litigation Case Tracker· Brennan Center for Justice